Biondo Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Biondo Investment Advisors, LLC

$724 Million
Q3 2024

A detailed history of Biondo Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Biondo Investment Advisors, LLC holds 25,095 shares of VRTX stock, worth $11.3 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

25,095

Previous 24,430 2.72%

Holding current value

$11.3 Million

Previous $11.5 Million 1.93%

% of portfolio

1.61%

Previous 1.71%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $305,900 - $336,343	665 Added 2.72%	25,095 $11.7 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $9.34 Million - $11.5 Million	23,765 Added 3573.68%	24,430 $11.5 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $33,818 - $36,246	-100 Reduced 13.07%	665 $231,000
Q1 2023 May 09, 2023	BUY	$283.23 - $323.1 $216,670 - $247,171	765 New	765 $241,000
Q2 2021 Aug 03, 2021	SELL	$187.49 - $221.1 $6 Million - $7.08 Million	-32,026 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$207.02 - $241.31 $7.73 Million - $9.01 Million	-37,342 Reduced 53.83%	32,026 $6.88 Million
Q4 2020 Feb 04, 2021	BUY	$207.01 - $276.09 $1.12 Million - $1.5 Million	5,430 Added 8.49%	69,368 $16.4 Million
Q3 2020 Nov 05, 2020	SELL	$255.65 - $303.1 $233,919 - $277,336	-915 Reduced 1.41%	63,938 $17.4 Million
Q2 2020 Aug 07, 2020	SELL	$225.48 - $295.8 $59,752 - $78,387	-265 Reduced 0.41%	64,853 $18.8 Million
Q1 2020 May 08, 2020	SELL	$199.77 - $247.81 $310,043 - $384,601	-1,552 Reduced 2.33%	65,118 $15.5 Million
Q4 2019 Feb 06, 2020	BUY	$166.71 - $223.91 $2.51 Million - $3.37 Million	15,040 Added 29.13%	66,670 $14.6 Million
Q3 2019 Nov 05, 2019	SELL	$166.23 - $187.09 $701,490 - $789,519	-4,220 Reduced 7.56%	51,630 $8.75 Million
Q2 2019 Aug 06, 2019	BUY	$164.61 - $190.37 $148,149 - $171,333	900 Added 1.64%	55,850 $10.2 Million
Q1 2019 May 08, 2019	BUY	$163.73 - $194.7 $1.46 Million - $1.74 Million	8,930 Added 19.4%	54,950 $10.1 Million
Q4 2018 Feb 08, 2019	BUY	$151.91 - $192.21 $564,345 - $714,060	3,715 Added 8.78%	46,020 $7.63 Million
Q3 2018 Nov 07, 2018	BUY	$167.73 - $192.74 $1.31 Million - $1.5 Million	7,785 Added 22.55%	42,305 $8.15 Million
Q2 2018 Aug 02, 2018	BUY	$145.72 - $169.96 $79,417 - $92,628	545 Added 1.6%	34,520 $5.87 Million
Q1 2018 May 02, 2018	BUY	$151.6 - $177.13 $715,552 - $836,053	4,720 Added 16.13%	33,975 $5.54 Million
Q4 2017 Feb 07, 2018	BUY	$137.28 - $155.55 $24,710 - $27,999	180 Added 0.62%	29,255 $4.38 Million
Q3 2017 Nov 08, 2017	BUY	$148.13 - $162.24 $4.31 Million - $4.72 Million	29,075	29,075 $4.42 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biondo Investment Advisors, LLC with notifications on news.

Account

Biondo Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History